CRISPR Therapeutics AG (CRSP) Receivables (2015 - 2024)
CRISPR Therapeutics AG's Receivables was $27.1 million in Q4 2024, down 86.9% from $206.5 million a year earlier.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Receivables (2015 - 2024) Analysis & Trends
From Q4 2015 onward, CRISPR Therapeutics AG has reported Receivables for 30 quarters.
- Receivables shows a five-year compound annual growth rate of 45.2% (FY2019 to FY2024).
- In earlier years, Receivables was $206.5 million in FY2023, $11.2 million in FY2022 (+28.7%), $8.71 million in FY2021 (-19.7%) and $10.84 million in FY2020 (+158.3%).
- The Q4 2024 figure marks the lowest quarterly Receivables since Q4 2022.
- The best year-over-year quarter for Receivables over five years was Q4 2020 (growth of 158.3%); the worst was Q1 2021 (a decline of 99.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 27.10 Mn |
| Dec 31, 2023 | 206.50 Mn |
| Jun 30, 2023 | 70.00 Mn |
| Dec 31, 2022 | 11.20 Mn |
| Sep 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Mar 31, 2022 | 143,000.00 |
| Dec 31, 2021 | 8.71 Mn |
| Sep 30, 2021 | 152,000.00 |
| Jun 30, 2021 | 150,000.00 |
| Mar 31, 2021 | 150,000.00 |
| Dec 31, 2020 | 10.84 Mn |
| Sep 30, 2020 | 25.11 Mn |
| Jun 30, 2020 | 25.03 Mn |
| Mar 31, 2020 | 50.12 Mn |
| Dec 31, 2019 | 4.20 Mn |
| Sep 30, 2019 | 25.04 Mn |
| Jun 30, 2019 | 642,000.00 |
| Mar 31, 2019 | 662,000.00 |
| Dec 31, 2018 | 176,000.00 |
API Access
CRISPR Therapeutics AG Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();